Dimitris Voliotis
Seminars
Wednesday 22nd July 2026
Advancing PET Imaging for the Assessment of Recurrent Brain Metastases
11:00 am
- Addressing the clinical challenge of differentiating tumor recurrence from treatment-related changes following radiotherapy
- Presenting the clinical development of 18F-RAD101 as a novel PET imaging agent designed to improve diagnostic accuracy
- Exploring the potential impact of PET imaging on patient management and clinical decision making in neuro-oncology
